<DOC>
	<DOC>NCT00782418</DOC>
	<brief_summary>This study will compare graded glucose infusion (GGI) to the hyperglycemic clamp (HGC) for assessment of glucose-dependent insulin secretion (GDIS) using exenatide as a probe.</brief_summary>
	<brief_title>A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Exenatide</mesh_term>
	<criteria>Subject has a Body Mass Index (BMI) of less than or equal to 26 kg/m2 at screening Subject is judged to be in good health Subject has been a nonsmoker for at least 3 months Subject is willing to avoid strenuous physical activity for the duration of the study Subject has a history of high blood pressure requiring treatment Subject has a history of diabetes or a family history of diabetes mellitus Subject is unable to discontinue all prescription and nonprescription drugs for duration of study Subject consumes more than 3 alcoholic beverages per day Subject consumes more than 6 servings of caffeinated beverages per day (1 serving = 120mg caffeine) Subject has had major surgery or has donated or loss 1 unit of blood within 4 weeks of screening Subject has multiple and/or severe allergies to foods or drugs Subject is a regular user of illegal drugs Subject is unwilling or unable to consume the standardized meals during the study and/or is on a carbohydrate restricted diet</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>